How about Doderer, Jabbour, Krishna Kowlgi, Toshi Ando and yes the lab techs. Or have they all left the company?
///answer: on LinkedIn Doderer is VP of r&d and Jabbour is CSO and BoD but is employed by U of Ottawa and the Canadian NRC. Kowlgi has always worked for TSU and might have consulted for QMC. Ando-San is now a consultant. Do you know who is doing what now? The company has not said and neither have the people you mentioned and your guess is as good as mine. If you think they are working for QMC, on projects other than blockchain, I would say it's possible it integrates blockchain into whatever they are working on because that is the path corporate and state businesses are taking these days. I'm not saying that, so don't misquote me please.
///
The only recent departures that I know of were Hartigan and Mcginniss, both health/software guys.
So QMC has a shelf full of ready to go QD products that they are just waiting for buyers to show up and buy? No ongoing internal R&D to make them better or expand the portfolio? No effort to actually sell any of these QD products or to sign a JV?
//)answer: You know QMC makes the best
QD and nanocrystals and nanoparticles.
Anyone can read the PRs and understand the how and why. It's not debatable, it's a fact. What Squires has said is QMC should be paid the value of the QD in whatever product a manufacturer wants to make, Some sort of JV and licensing and royalties accomplishes that goal and he has stuck to this principle. That's the business plan.
There is no need for further R&D on their QD, which are the best now because they have the best brightness or whatever technical term you want to insert there, and they are environmentally resistant to air, heat and moisture and can be mass produced in any quantity. It's a near perfect QD, and it's ready for commercialization.
In simple terms, a JV involving QD would need QMC to manufacture a specific QD. Years ago I posted a list of over 20 QD and nanocrystals they could make and had listed in their online store at the time. So the QD are not a problem for type or quality or quantity.
The other parts of the JV are:
1. working capital; Investment
2. Factory; place of manufacturer
3. The IP; Patented technology
4. Development and License and royalties to QMC. Other profits generated are the partner's. It's a fair deal. It's not QMC'S fault if they turn down deals that don't fit the parameters of the business plan, if that's what happened. Instead I see Squires learning from each deal experience and evolving and improving.
The JV partner is responsible for 1 to 4.
///
“If course, I expect Assam researchers are already working at the minimum on PPE related projects since I believe at least one reactor is up and running. Other QD applications are possibly being worked on.”
When I listen to the AMTRON Foundation Day video (https://www.youtube.com/watch?v=Ei4Mn_YIgXM&t=1299s) , I hear a lot about AMTRON’s main mission, providing internet and IT services to the State of Assam, and a remote possibility that they could start up one of the reactors and produce nanoparticles to be provided to others for possible PPE applications. Just produce a commodity that others may be able to use to produce a product. No research by AMTRON to discover new QD applications.
In the video, I saw a bigger need for AMTRON to fulfill its IT mission by providing IT services to the Indian health services, schools, government, businesses and the people of Assam, rather than exploring new business opportunities.
///answer: The main mission of AMTRON is providing state services in IT and building business through economic development. I remind you that QMC'S Licencee is the Anchor Tenant for the Electronics Manufacturing Complex, and the plan is to build a now estimated 75,000 SQ ft factory for them. That's big!
But there is a big misunderstanding if you think a building is necessary to get QD production started. All that's needed is one or two small labs for the reactor, it could be placed in the India-reknown Nanotech University connected to the eminent IITG.
Best of all the reactors are automated and software controlled so once setup, operations are teachable IMO. Its not easy to get into IITG, so no doubt they can easily handle the work.///
First AMTRON would need QMC to remotely set up the reactor and then teach AMTRON how to produce nanoparticles. If this could be done so AMTRON could produce and sell gold nanoparticles to PPE manufacturers in India, then why hasn’t QMC been producing nanoparticles in San Marco since April and selling them in the U.S. or to India? Maybe not a high margin commodity, but a saleable product to keep the wet lab reactors up and running and a great PR opportunity for QMC in the midst of the Covid crisis, while QDXH was bringing the App to market.
///answer: mostly already answered above. I will just summarize that QMC has no reason to produce QD without paid clients. The results of QMC'S tests on its QD or samples would be subject to NDA and or contacts, and we know that right now QMC is a non-reporting Pink with no obligation to report stages of progress, especially because I think it is generally agreed that revenue will move the stock.///
I don’t buy the idea that the Indian IT people have been spending the last three months developing new QDs or new QD applications. I don’t think that they have the time, the money, or other resources to do it.
///answer: First, it's not that the PPE IP is new, it's actually all over the internet these days. The ability to manufacture the best nanomaterials, with high quantity and quality, in a JV, where the QD are contributed to the project to lower the startup cost to presumably a clothing manufacturer with an idle factory that can attract investors, and where there are India government programs for this, is what's new. Think bigger, my friend. Squires is not limited by your expectations of puny QD sales.///
///answer: on LinkedIn Doderer is VP of r&d and Jabbour is CSO and BoD but is employed by U of Ottawa and the Canadian NRC. Kowlgi has always worked for TSU and might have consulted for QMC. Ando-San is now a consultant. Do you know who is doing what now? The company has not said and neither have the people you mentioned and your guess is as good as mine. If you think they are working for QMC, on projects other than blockchain, I would say it's possible it integrates blockchain into whatever they are working on because that is the path corporate and state businesses are taking these days. I'm not saying that, so don't misquote me please.
///
The only recent departures that I know of were Hartigan and Mcginniss, both health/software guys.
So QMC has a shelf full of ready to go QD products that they are just waiting for buyers to show up and buy? No ongoing internal R&D to make them better or expand the portfolio? No effort to actually sell any of these QD products or to sign a JV?
//)answer: You know QMC makes the best
QD and nanocrystals and nanoparticles.
Anyone can read the PRs and understand the how and why. It's not debatable, it's a fact. What Squires has said is QMC should be paid the value of the QD in whatever product a manufacturer wants to make, Some sort of JV and licensing and royalties accomplishes that goal and he has stuck to this principle. That's the business plan.
There is no need for further R&D on their QD, which are the best now because they have the best brightness or whatever technical term you want to insert there, and they are environmentally resistant to air, heat and moisture and can be mass produced in any quantity. It's a near perfect QD, and it's ready for commercialization.
In simple terms, a JV involving QD would need QMC to manufacture a specific QD. Years ago I posted a list of over 20 QD and nanocrystals they could make and had listed in their online store at the time. So the QD are not a problem for type or quality or quantity.
The other parts of the JV are:
1. working capital; Investment
2. Factory; place of manufacturer
3. The IP; Patented technology
4. Development and License and royalties to QMC. Other profits generated are the partner's. It's a fair deal. It's not QMC'S fault if they turn down deals that don't fit the parameters of the business plan, if that's what happened. Instead I see Squires learning from each deal experience and evolving and improving.
The JV partner is responsible for 1 to 4.
///
“If course, I expect Assam researchers are already working at the minimum on PPE related projects since I believe at least one reactor is up and running. Other QD applications are possibly being worked on.”
When I listen to the AMTRON Foundation Day video (https://www.youtube.com/watch?v=Ei4Mn_YIgXM&t=1299s) , I hear a lot about AMTRON’s main mission, providing internet and IT services to the State of Assam, and a remote possibility that they could start up one of the reactors and produce nanoparticles to be provided to others for possible PPE applications. Just produce a commodity that others may be able to use to produce a product. No research by AMTRON to discover new QD applications.
In the video, I saw a bigger need for AMTRON to fulfill its IT mission by providing IT services to the Indian health services, schools, government, businesses and the people of Assam, rather than exploring new business opportunities.
///answer: The main mission of AMTRON is providing state services in IT and building business through economic development. I remind you that QMC'S Licencee is the Anchor Tenant for the Electronics Manufacturing Complex, and the plan is to build a now estimated 75,000 SQ ft factory for them. That's big!
But there is a big misunderstanding if you think a building is necessary to get QD production started. All that's needed is one or two small labs for the reactor, it could be placed in the India-reknown Nanotech University connected to the eminent IITG.
Best of all the reactors are automated and software controlled so once setup, operations are teachable IMO. Its not easy to get into IITG, so no doubt they can easily handle the work.///
First AMTRON would need QMC to remotely set up the reactor and then teach AMTRON how to produce nanoparticles. If this could be done so AMTRON could produce and sell gold nanoparticles to PPE manufacturers in India, then why hasn’t QMC been producing nanoparticles in San Marco since April and selling them in the U.S. or to India? Maybe not a high margin commodity, but a saleable product to keep the wet lab reactors up and running and a great PR opportunity for QMC in the midst of the Covid crisis, while QDXH was bringing the App to market.
///answer: mostly already answered above. I will just summarize that QMC has no reason to produce QD without paid clients. The results of QMC'S tests on its QD or samples would be subject to NDA and or contacts, and we know that right now QMC is a non-reporting Pink with no obligation to report stages of progress, especially because I think it is generally agreed that revenue will move the stock.///
I don’t buy the idea that the Indian IT people have been spending the last three months developing new QDs or new QD applications. I don’t think that they have the time, the money, or other resources to do it.
///answer: First, it's not that the PPE IP is new, it's actually all over the internet these days. The ability to manufacture the best nanomaterials, with high quantity and quality, in a JV, where the QD are contributed to the project to lower the startup cost to presumably a clothing manufacturer with an idle factory that can attract investors, and where there are India government programs for this, is what's new. Think bigger, my friend. Squires is not limited by your expectations of puny QD sales.///
